Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Prophylactic Valproate in Moderate or Severe Traumatic Brain Injury
ChiCTR-OPC-16007687Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of valproic acid in epilepsy and traumatic brain injury (TBI) (2 arms), sponsored by Huashan Hospital. Primary endpoints: Serum valproate concentration, Seizure attack and 1 more. Started Jan 2016; status: recruiting.
02
Drugs
valproic acid
03
Conditions
epilepsytraumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR-OPC-16007687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16007687.